Exploratory Efficacy and Safety, Pharmacokinetics and Dose Finding Study of ATryn (Antithrombin Alfa) in Patients With Disseminated Intravascular Coagulation Associated With Severe Sepsis.

Trial Profile

Exploratory Efficacy and Safety, Pharmacokinetics and Dose Finding Study of ATryn (Antithrombin Alfa) in Patients With Disseminated Intravascular Coagulation Associated With Severe Sepsis.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Antithrombin alfa (Primary)
  • Indications Disseminated intravascular coagulation; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database record.
    • 19 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 20 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top